Management of the active severe eye changes of Graves' disease.
作者信息
Werner S C
出版信息
Trans Am Acad Ophthalmol Otolaryngol. 1967 Jul-Aug;71(4):631-7.
PMID:6072401
Abstract
摘要
相似文献
1
Management of the active severe eye changes of Graves' disease.格雷夫斯病活动性严重眼部病变的管理
Trans Am Acad Ophthalmol Otolaryngol. 1967 Jul-Aug;71(4):631-7.
2
Graves's disease and total thyroidectomy. Progression of severe eye changes and decrease in serum long acting thyroid stimulator after operation.
N Engl J Med. 1967 Jan 19;276(3):132-8. doi: 10.1056/NEJM196701192760302.
3
Large doses of radioiodide in Graves' disease: effect on ophthalmopathy and long-acting thyroid stimulator.大剂量放射性碘在格雷夫斯病中的应用：对眼病和长效甲状腺刺激素的影响
Mayo Clin Proc. 1967 Dec;42(12):802-11.
4
[Etiology and treatment of Graves' disease (some problems)].
Nord Med. 1968 Dec 5;80(49):1645-50.
5
The choices of therapy in Graves' disease.
Med Times. 1970 Nov;98(11):105-20.
6
Thyroid eye disease.
Trans Ophthalmol Soc N Z. 1974;26(0):45-50.
7
Medical approach to ophthalmopathy of Graves' disease.格雷夫斯病眼病的医学治疗方法。
Mayo Clin Proc. 1972 Dec;47(12):980-5.
8
Observations against a causal relationship between the long-acting thyroid stimulator and ophthalmopathy in Graves' disease.关于长效甲状腺刺激素与格雷夫斯病中眼病变之间因果关系的观察。
J Clin Endocrinol Metab. 1968 Aug;28(8):1177-82. doi: 10.1210/jcem-28-8-1177.
9
The long-acting thyroid stimulator and thyroid disease.长效甲状腺刺激素与甲状腺疾病
Adv Intern Med. 1970;16:135-54.
10
["Long-acting thyroid stimulator" and thyrotropic hormone in thyrotoxicosis in newborn infants].["长效甲状腺刺激素"与新生儿甲状腺毒症中的促甲状腺激素]
Schweiz Med Wochenschr. 1968 Jan 6;98(1):8-12.
Zotero 插件